Wall Street Zen lowered shares of Wellgistics Health (NASDAQ:WGRX - Free Report) from a hold rating to a sell rating in a research report report published on Saturday.
Wellgistics Health Stock Performance
WGRX traded down $0.11 during midday trading on Friday, hitting $0.88. The company had a trading volume of 545,548 shares, compared to its average volume of 2,257,335. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.15 and a current ratio of 0.36. Wellgistics Health has a twelve month low of $0.75 and a twelve month high of $7.04.
About Wellgistics Health
(
Get Free Report)
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
Featured Articles
Before you consider Wellgistics Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Wellgistics Health wasn't on the list.
While Wellgistics Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access